Found 6 matching trials
Extension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma PHASE2 The main objective of this study is to assess the long-term effectiveness o...
Show More Location
Multiple Locations
Learn More & Join Trial
SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes. PHASE2 The purpose of this study is to determine the safety and effectiveness of o...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Oral SCIO-469 Pharmacokinetics (Study of a Drug in the Body to Watch How the Drug is Absorbed, Distributed, Metabolized and Eliminated Over a Period of Time) in the Body of Female Patients With Active Rheumatoid Arthritis PHASE1 The purpose of this study is to assess the pharmacokinetics of two oral dos...
Show More Location
Multiple Locations
Learn More & Join Trial
SPRiNG: SCIO-469 Patients With Rheumatoid Arthritis Not Receiving Methotrexate PHASE2 The primary objective of this study is to determine the efficacy of oral SC...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma PHASE2 The main objective of this study is to assess the efficacy of SCIOS-469 as ...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety Study of SCIO-469 to Treat Patients With Active Rheumatoid Arthritis Receiving Methotrexate PHASE2 The main objective of the study is to evaluate the safety and tolerability ...
Show More Location
Multiple Locations
Learn More & Join Trial